OptimizeRx Corporation (OTCMKTS:OPRX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
On November 30, 2016, Mr. James Brooks moved to a consulting role
with our company. Effective on that date, Mr. Brooks will no
longer serve as our Senior Vice President of Business
Development. We agreed to pay all compensation and reimbursable
expenses through December 31, 2016. Mr. Brooks has also provided
us a release of all claims in connection with the end of his
employment relationship and move to his consulting role.
Commencing January 1, 2017, Mr. Brooks will serve as a consultant
for one year and assist with our selling efforts to EHRs. For his
consulting, we have agreed to compensate him a fee for each
signed and integrated EHR plus a percentage of the net revenues
received from such EHRs during his consulting period. Special
projects will be billed to us at an hourly rate.
About OptimizeRx Corporation (OTCMKTS:OPRX)
OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company’s principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs. OptimizeRx Corporation (OTCMKTS:OPRX) Recent Trading Information
OptimizeRx Corporation (OTCMKTS:OPRX) closed its last trading session down -0.030 at 0.820 with 4,000 shares trading hands.
